Back
Lockheed Martin 10K Form
Sell
29
LMT
Lockheed Martin
Last Price:
546.70
Seasonality Move:
3.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-23 | 10Q | LMT/Lockheed Martin Quarterly |
2024-01-23 | 10K | LMT/Lockheed Martin Annual |
2023-10-17 | 10Q | LMT/Lockheed Martin Quarterly |
2023-07-19 | 10Q | LMT/Lockheed Martin Quarterly |
2023-04-18 | 10Q | LMT/Lockheed Martin Quarterly |
2023-01-26 | 10K | LMT/Lockheed Martin Annual |
Receive LMT News And Ratings
See the #1 stock for the next 7 days that we like better than LMT
LMT Financial Statistics
Sales & Book Value
Annual Sales: | $67.57B |
---|---|
Cash Flow: | $2.08B |
Price / Cash Flow: | 20.28 |
Annual Sales: | $30.77 |
Price / Book: | 17.85 |
Profitability
EPS (TTM): | 27.62000 |
---|---|
Net Income (TTM): | $6.68B |
Gross Margin: | $8.48B |
Return on Equity: | 92.37% |
Return on Assets: | 12.15% |
Lockheed Martin Earnings Forecast
Key Lockheed Martin Financial Ratios
- The Gross Profit Margin over the past 32 years for LMT is 12.55%.
- The Selling, General & Administrative Expenses for LMT have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 13.24% of Operating Income.
- The Net Earning history of LMT is 10.24% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 21 years.
Lockheed Martin Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Aerospace & Defense |
Sector: | Industrials |
Current Symbol: | LMT |
CUSIP: | 539830 |
Website: | lockheedmartin.com |
Debt
Debt-to-Equity Ratio: | 2.68 |
---|---|
Current Ratio: | 1.3 |
Quick Ratio: | 1.1 |
Price-to-Earnings
Trailing P/E Ratio: | 19.85 |
---|---|
Forward P/E Ratio: | 19.63 |
LMT Technical Analysis vs Fundamental Analysis
Sell
29
Lockheed Martin (LMT)
is a Sell
Is Lockheed Martin a Buy or a Sell?
-
Lockheed Martin stock is rated a Sell
The current Lockheed Martin [LMT] share price is $546.75. The Score for LMT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.